{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:13:49Z","timestamp":1786374829507,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.2459\/jcm.0b013e3283454faa","type":"journal-article","created":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T03:53:15Z","timestamp":1301457195000},"page":"305-308","source":"Crossref","is-referenced-by-count":7,"title":["Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction"],"prefix":"10.2459","volume":"12","author":[{"given":"Giuseppe","family":"Patti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210207","first-page":"1383","article-title":"4444 patients with coronary heart disease: the Scandinavian Sinvastatin Survival Study (4S).","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"R2-1-20210207","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2005.05.085","article-title":"Pleiotropic effects of statins: benefit beyond cholesterol reduction?","volume":"46","author":"Robinson","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R4-1-20210207","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.CIR.0000137828.06205.87","article-title":"Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study","volume":"110","author":"Pasceri","year":"2004","journal-title":"Circulation"},{"key":"R5-1-20210207","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jacc.2007.02.025","article-title":"Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial","volume":"49","author":"Patti","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R6-1-20210207","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jacc.2009.05.028","article-title":"Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial","volume":"54","author":"Di Sciascio","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R7-1-20210207","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ehj.2004.07.017","article-title":"Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction","volume":"25","author":"Briguori","year":"2004","journal-title":"Eur Heart J"},{"key":"R8-1-20210207","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jacc.2009.07.005","article-title":"Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction","volume":"54","author":"Briguori","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R9-1-20210207","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcin.2009.11.021","article-title":"Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial","volume":"3","author":"Kim","year":"2010","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"R10-1-20210207","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.amjcard.2009.04.048","article-title":"Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study","volume":"104","author":"Veselka","year":"2009","journal-title":"Am J Cardiol"},{"key":"R11-1-20210207","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijcard.2008.06.055","article-title":"The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome","volume":"137","author":"Yun","year":"2009","journal-title":"Int J Cardiol"},{"key":"R12-1-20210207","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF02848771","article-title":"Does pravastatin therapy affect cardiac enzyme levels after percutaneous coronary intervention?","volume":"24","author":"Bozbas","year":"2007","journal-title":"Adv Ther"},{"key":"R13-1-20210207","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1253\/circj.71.1225","article-title":"Randomized trial of statin administration for myocardial injury: is intensive lipid-lowering more beneficial than moderate lipid-lowering before percutaneous coronary intervention?","volume":"71","author":"Kinoshita","year":"2007","journal-title":"Circ J"},{"key":"R14-1-20210207","first-page":"659","article-title":"Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome","volume":"122","author":"Jia","year":"2009","journal-title":"Chin Med J"},{"key":"R15-1-20210207","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1753944709338893","article-title":"Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study","volume":"3","author":"Hara","year":"2009","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"R16-1-20210207","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10557-010-6224-1","article-title":"Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin","volume":"24","author":"Cay","year":"2010","journal-title":"Cardiovasc Drugs Ther"},{"key":"R17-1-20210207","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.CIR.0000153810.81187.7D","article-title":"Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients","volume":"111","author":"Sanguigni","year":"2005","journal-title":"Circulation"},{"key":"R18-1-20210207","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.amjcard.2005.02.050","article-title":"Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography","volume":"96","author":"Hinoi","year":"2005","journal-title":"Am J Cardiol"},{"key":"R19-1-20210207","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/01.RES.0000099503.13312.7B","article-title":"Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on coronary endothelial function","volume":"93","author":"Wassmann","year":"2003","journal-title":"Circ Res"},{"key":"R20-1-20210207","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jacc.2006.06.061","article-title":"Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy","volume":"48","author":"Patti","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R21-1-20210207","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jacc.2005.01.021","article-title":"Failure to protect the myocardium against ischemia\/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?","volume":"45","author":"Mensah","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R22-1-20210207","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/hc0502.104278","article-title":"Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?","volume":"105","author":"Akkerhuis","year":"2002","journal-title":"Circulation"},{"key":"R23-1-20210207","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0735-1097(03)01044-1","article-title":"Mortality risk conferred by small elevations of creatine-kinase MB isoenzyme after percutaneous intervention","volume":"42","author":"Ioannidis","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R24-1-20210207","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2459\/JCM.0b013e328341024f","article-title":"Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.","volume":"12","author":"Toso","year":"2011","journal-title":"J Cardiovasc Med"},{"key":"R25-1-20210207","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.ehj.2004.08.016","article-title":"Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13 307 patients in five TIMI trials","volume":"25","author":"Gibson","year":"2004","journal-title":"Eur Heart J"},{"key":"R26-1-20210207","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0002-9149(00)01442-9","article-title":"Evaluation of long term survival after successful percutaneous coronary intervention among patients with chronic renal failure","volume":"87","author":"Ting","year":"2001","journal-title":"Am J Cardiol"},{"key":"R27-1-20210207","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","article-title":"Contrast-induced acute kidney injury","volume":"51","author":"McCullough","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R28-1-20210207","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0735-1097(00)00917-7","article-title":"The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with preexistent chronic renal insufficiency","volume":"36","author":"Gruberg","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R29-1-20210207","doi-asserted-by":"crossref","first-page":"14K","DOI":"10.1016\/j.amjcard.2006.01.020","article-title":"Pathophysiology of contrast-induced nephropathy","volume":"98","author":"Tumlin","year":"2006","journal-title":"Am J Cardiol"},{"key":"R30-1-20210207","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.amjcard.2007.08.030","article-title":"Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention","volume":"101","author":"Patti","year":"2008","journal-title":"Am J Cardiol"}],"container-title":["Journal of Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01244665-201105000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:18:52Z","timestamp":1786371532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01244665-201105000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2459\/jcm.0b013e3283454faa","relation":{},"ISSN":["1558-2027"],"issn-type":[{"value":"1558-2027","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}